{
  "id": "SCR-LIP-000747",
  "statement": "DXA regional fat measures are used in lipedema studies as descriptive variables or as proxy definitions of a lipedema-like phenotype.",
  "claim_type": "clinical_association",
  "context": {
    "population": "single woman with lipedema",
    "condition": "lipedema",
    "exposure": "DXA body composition assessment",
    "comparator": "—",
    "outcome": "regional fat masses and android-to-gynoid fat ratio",
    "scope": "auto-ingested from Layer 1 surveillance"
  },
  "knowledge_state": "emerging",
  "evidence_confidence": "low",
  "evidence": [
    {
      "title": "JCEM Case Reports, 2026, 4, luag018",
      "ref": "DOI:10.1210/jcemcr/luag018",
      "stance": "supporting",
      "study_design": "case_report",
      "n": null,
      "risk_of_bias": "unknown",
      "grade": "very_low",
      "year": 2026,
      "amato_authored": false,
      "quote": "Total body, trunk, leg and arm fat masses, the android-to-gynoid fat ratio (in general, the android region is the area between the lower ribs and the pelvis and the gynoid region is the area below the pelvis to the upper thighs) and fat-free mass were assessed by using dual-energy X-ray absorptiomet",
      "extraction_confidence": "moderate",
      "note": "The abstract describes DXA being applied to a lipedema patient to measure regional fat distribution, but as a single case report it does not test or validate DXA's ability to identify a characteristic lipedema fat distribution pattern; it i",
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": true,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "context",
        "verdict": "verified",
        "reason": "The article explicitly describes using DXA (Lunar iDXA) to assess total body, trunk, leg, and arm fat masses and the android-to-gynoid fat ratio, alongside MRI for regional adipose tissue volumes, in a single lipedema patient case report. T",
        "date": "2026-09-20"
      },
      "stance_in_source_claim": "context",
      "finding": "Case report: DXA assessed total, trunk, leg and arm fat masses and android-to-gynoid ratio in a lipedema patient, alongside MRI regional volumes.",
      "from_claims": [
        "SCR-LIP-000439"
      ]
    },
    {
      "title": "Unveiling kinesiophobia: A hidden challenge",
      "ref": "DOI:10.1177/02683555251360606",
      "stance": "supporting",
      "study_design": "case_control",
      "n": null,
      "risk_of_bias": "unknown",
      "grade": "low",
      "year": 2026,
      "amato_authored": false,
      "quote": "the lipedema patients were evaluated in terms of extremity volumes, and total and mean lower extremity fat mass by dualenergy X-ray absorptiometry",
      "extraction_confidence": "high",
      "note": "DXA is used to measure lower extremity fat mass in lipedema patients, but the abstract does not test whether DXA identifies a lipedema-specific fat distribution pattern; it only uses DXA as a measurement tool within a kinesiophobia study, m",
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": true,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "context",
        "verdict": "verified",
        "reason": "The article confirms DXA was used to measure total and mean lower extremity fat mass in 40 lipedema patients, and explicitly states no difference was found between high and low kinesiophobia groups in fat mass or extremity volumes. The stat",
        "date": "2026-09-20"
      },
      "stance_in_source_claim": "context",
      "finding": "In 40 lipedema patients, DXA lower-extremity fat mass did not differ between high and low kinesiophobia groups.",
      "from_claims": [
        "SCR-LIP-000440"
      ]
    },
    {
      "ref": "DOI:10.64898/2025.12.01.25341350",
      "stance": "supporting",
      "study_design": "cross_sectional",
      "n": 3833,
      "risk_of_bias": "moderate",
      "year": 2025,
      "amato_authored": true,
      "note": "exploratory; DXA proxy may capture gynoid obesity",
      "title": "The Lipedema Phenotype is Inversely Associated with Celiac Disease Autoimmunity: Testing the Immunological Shield Hypothesis in NHANES",
      "authors": "Amato et al.",
      "grade": "low",
      "_prov": {
        "grade_source": "bib_curated"
      },
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": true,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "supporting",
        "verdict": "verified",
        "reason": "The article explicitly reports HOMA-IR 44.2% lower in the lipedema phenotype group (1.35 vs 2.42, p<0.001) and NLR 7.6% lower (1.96 vs 2.12, p=0.012) in NHANES women, matching the statement exactly.",
        "date": "2026-06-10"
      },
      "quote": "HOMA-IR mediano 44,2% menor no fenótipo lipedema (1,35 [IQR 0,95–2,01] vs 2,42 [IQR 1,47–4,30]; p<0,001)",
      "extraction_confidence": "high",
      "stance_in_source_claim": "supporting",
      "finding": "In NHANES women, a lipedema-like phenotype defined by DXA leg-to-trunk fat ratio >90th percentile had 44.2% lower HOMA-IR (p<0.001); exploratory, unvalidated proxy.",
      "from_claims": [
        "SCR-LIP-000027"
      ]
    },
    {
      "ref": "DOI:10.7759/cureus.104222",
      "stance": "supporting",
      "study_design": "cross_sectional",
      "n": null,
      "risk_of_bias": "unknown",
      "grade": "low",
      "year": 2026,
      "amato_authored": true,
      "note": "Exploratory cross-sectional population study directly examines whether a peripheral/gynoid (lipedema-like) fat distribution confers metabolic protection, reporting lower HOMA-IR and reduced diabetes prevalence with dose-response; supports t",
      "title": "Exploring the Immunological Shield Hypothesis: A Population-Based Exploration of Phenotypic Divergence Between Lipedema and Celiac Disease Autoimmunity",
      "authors": "Amato et al.",
      "journal": "Cureus",
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": false,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "supporting",
        "verdict": "verified",
        "reason": "verified by verifier; quote not verbatim-grounded. The article explicitly reports HOMA-IR median 44.2% lower (1.35 vs 2.42; p<0.001) and NLR 7.6% lower (1.96 vs 2.12; p=0.012) in the lipedema phenotype group, matching the statement's number",
        "date": "2026-06-10"
      },
      "quote": "fenótipo lipedema fortemente protetor contra diabetes (prevalência 1,8% vs 8,1%; OR 0,21; IC95% 0,08-0,51; p<0,001)",
      "extraction_confidence": "high",
      "stance_in_source_claim": "supporting",
      "finding": "The same DXA-defined lipedema-like phenotype was associated with lower diabetes prevalence (1.8% vs 8.1%; OR 0.21) in an exploratory population analysis.",
      "from_claims": [
        "SCR-LIP-000027"
      ]
    }
  ],
  "relations": [],
  "gaps": "",
  "curators": [],
  "created": "2026-11-20",
  "updated": "2026-11-20",
  "license": "CC-BY-4.0",
  "consolidated_from": [
    "SCR-LIP-000439",
    "SCR-LIP-000440",
    "SCR-LIP-000027"
  ],
  "questions_consolidated": [
    "SQ-LIP-000031"
  ],
  "provenance": {
    "method": "consolidation (R-CLM-19)",
    "store_key": "G-00193",
    "models": {
      "primary": "claude-opus-5.5 (Claude Code subagent, 1 repair round + arbitration)",
      "verifier": "claude-sonnet (Claude Code subagent, fresh context)",
      "mode": "agent"
    }
  },
  "history": [
    {
      "date": "2026-11-20",
      "event": "created_by_consolidation",
      "detail": "general proposition consolidated from SQ-LIP-000031"
    }
  ],
  "statement_pt": "As medidas regionais de gordura por DXA são usadas em estudos de lipedema como variáveis descritivas ou como definições substitutas de um fenótipo semelhante ao do lipedema.",
  "answers_questions": [
    {
      "id": "SQ-LIP-000031",
      "role": "context",
      "question": "Can DXA (dual-energy X-ray absorptiometry) help identify lipedema fat distribution?",
      "url": "https://scientificclaims.org/q/SQ-LIP-000031.html"
    }
  ],
  "url": "https://scientificclaims.org/c/SCR-LIP-000747.html"
}